SCHEMBL22304510

SCHEMBL22304510

O=C1COC(c2cnc(Cl)c(C(F)(F)F)c2)=NN1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAOB P27338 14/20 0.46
PIK3CD O00329 1/20 0.43
PDE3B Q13370 5/20 0.43
PDE3A Q14432 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22288636 0.81 PDE3B (0.62) MAOBPDE3BPDE3A
SCHEMBL22304682 0.79 CNR2 (0.47) MAOBPDE3BPDE3A
SCHEMBL22288612 0.78 PDE3B (0.41) MAOBPDE3BPDE3A
SCHEMBL22288394 0.77 PDE3B (0.49) MAOBPDE3BPDE3A
SCHEMBL22288640 0.77 PDE3B (0.48) MAOBPDE3BPDE3A
SCHEMBL22317136 0.77 PDE3B (0.67) PDE3BPDE3A
SCHEMBL22288706 0.76 MAOB (0.50) MAOBPDE3BPDE3A
SCHEMBL22288970 0.76 PDE3B (0.63) MAOBPDE3BPDE3A
SCHEMBL22304517 0.75 PDE3B (0.47) MAOBPDE3BPDE3A
SCHEMBL22288607 0.75 MAOB (0.47) MAOBPDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020157201-A1 OXADIAZINONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed